Human medicines European public assessment report (EPAR): Kadcyla, trastuzumab emtansine, Date of authorisation: 15/11/2013, Revision: 18, Status: Authorised

Submitted by Anonymous (not verified) on 16 June 2026 - 8:35

Human medicines European public assessment report (EPAR): Kadcyla, trastuzumab emtansine, Date of authorisation: 15/11/2013, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Ziihera, zanidatamab, Date of authorisation: 27/06/2025, Revision: 2, Status: Authorised

Submitted by Anonymous (not verified) on 16 June 2026 - 8:20

Human medicines European public assessment report (EPAR): Ziihera, zanidatamab, Date of authorisation: 27/06/2025, Revision: 2, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Startvac, adjuvanted inactivated vaccine for cattle against Staphylococcus aureus, coliforms and coagulase-negative staphylococci, Status: Authorised

Submitted by Anonymous (not verified) on 15 June 2026 - 16:16

Veterinary medicines European public assessment report (EPAR): Startvac, adjuvanted inactivated vaccine for cattle against Staphylococcus aureus, coliforms and coagulase-negative staphylococci, Status: Authorised

Human medicines European public assessment report (EPAR): Lonquex, lipegfilgrastim, Date of authorisation: 25/07/2013, Revision: 29, Status: Authorised

Submitted by Anonymous (not verified) on 15 June 2026 - 16:14

Human medicines European public assessment report (EPAR): Lonquex, lipegfilgrastim, Date of authorisation: 25/07/2013, Revision: 29, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness